Svoronos Dawn
Director at XENE; Director at Global Blood Therapeutics, Inc.; Director at PTCT, and 1 more
- Sold, on record
- $2.3M
- Dollars the filings state
- Form 4 sales
- 12
- Latest Aug 24, 2023
- Form 144 notices
- 1
- Proposed sales
- Companies
- 4
- Filed as an executive or holder
Companies
- XENEXenon Pharmaceuticals Inc.Director
- Global Blood Therapeutics, Inc.Director
- PTCTPTC THERAPEUTICS, INC.Director
- MEDIVATION, INC.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- XENE25,000 shares
- MEDIVATION, INC.12,450 shares
- Global Blood Therapeutics, Inc.6,061 shares
- PTCT2,483 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale PTCTPlan not statedFeb 1 2021
Sold 506 shares at $56.96 ($29k)
Svoronos Dawn, Director
Sold 1.8% of holdings ($1.6M position)27,430 shares leftFiling
- 2 Form 4 sale PTCTPlan not statedJun 9 +128 days
Sold 365 shares at $41.89 ($15k)
Svoronos Dawn, Director
Sold 1.3% of holdings ($1.1M position)27,065 shares leftFiling
- 3 Form 4 sale Global Blood Therapeutics, Inc.UnusualJun 18 +9 days
Sold 1,609 shares at $36.54 ($59k)
Svoronos Dawn, Director
Sold 30.4% of holdings ($193k position)3,684 shares leftFiling
- 4 Form 4 sale PTCTPlan not statedJan 7 +203 days
Sold 510 shares at $38.53 ($20k)
Svoronos Dawn, Director
Sold 1.9% of holdings ($1M position)26,555 shares left1.4x usual sizeFiling
- 5 Form 4 sale PTCTPlan not statedJun 9 +153 days
Sold 738 shares at $27.20 ($20k)
Svoronos Dawn, Director
Sold 2.5% of holdings ($809k position)29,017 shares left1.7x usual sizeFiling
- 6 Form 4 sale Global Blood Therapeutics, Inc.UnusualJun 21 +12 days
Sold 1,908 shares at $27.24 ($52k)
Svoronos Dawn, Director
Sold 26.2% of holdings ($198k position)5,376 shares leftFiling
- 7 Form 144 notice XENENoticeAug 24 +429 days
Filed to sell 25,000 shares ($968k)
Svoronos Dawn, Director
No 10b5-1 planFirst sale on recordFiling
- 8 Form 4 sale XENEUnusualAug 24 same day
Sold 25,000 shares at $38.70 ($968k)
Svoronos Dawn, Director
No 10b5-1 planSold 50% of holdings ($1.9M position)25,000 shares leftFirst sale on recordFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (13)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Aug 24, 2023 | XENE | Director | Form 4 sale | 25,000 | $968k | 50.0% | Unusual | SEC |
| Aug 24, 2023 | XENE | Director | Form 144 notice | 25,000 | $968k | Notice | SEC | |
| Jun 21, 2022 | Global Blood Therapeutics, Inc. | Director | Form 4 sale | 1,908 | $52k | 26.2% | Unusual | SEC |
| Jun 9, 2022 | PTCT | Director | Form 4 sale | 738 | $20k | 2.5% | Plan not stated | SEC |
| Jan 7, 2022 | PTCT | Director | Form 4 sale | 510 | $20k | 1.9% | Plan not stated | SEC |
| Jun 18, 2021 | Global Blood Therapeutics, Inc. | Director | Form 4 sale | 1,609 | $59k | 30.4% | Unusual | SEC |
| Jun 9, 2021 | PTCT | Director | Form 4 sale | 365 | $15k | 1.3% | Plan not stated | SEC |
| Feb 1, 2021 | PTCT | Director | Form 4 sale | 506 | $29k | 1.8% | Plan not stated | SEC |
| Jun 19, 2020 | Global Blood Therapeutics, Inc. | Director | Form 4 sale | 2,544 | $163k | 53.0% | Unusual | SEC |
| Jun 11, 2020 | PTCT | Director | Form 4 sale | 364 | $18k | 1.4% | Plan not stated | SEC |
| Mar 14, 2016 | MEDIVATION, INC. | Director | Form 4 sale | 6,000 | $233k | 24.8% | Plan not stated | SEC |
| Sep 8, 2015 | MEDIVATION, INC. | Director | Form 4 sale | 3,100 | $276k | 20.4% | Plan not stated | SEC |
| Mar 2, 2015 | MEDIVATION, INC. | Director | Form 4 sale | 3,350 | $401k | 19.7% | Plan not stated | SEC |